Julianne Dorn Professor of Neurology, Harvard Medical School
Friday, August 9, 2019
12:00 - 1:00 PM EDT
An update on targets and treatments in development will be shared. In addition, Dr. Cudkowicz will share information on the Healey ALS Platform Trial - the first adaptive Master Protocol trial initiative in ALS.
